$1M Trimmed From $4.8M Award Over Remicade Ads

By Pete Brush

Law360, New York (March 09, 2010, 2:18 PM ET) -- A Texas appeals court has stripped $1 million from a $4.8 million award to a couple who claimed Johnson & Johnson Inc. subsidiary Centocor Inc.'s advertising misled them into thinking its Remicade drug was safe.

The Texas Court of Appeals for the Thirteenth District sustained the drug company's challenge to a $1 million award of future damages Thursday, saying plaintiffs Patricia and Thomas Hamilton failed to prove such damages at trial.

But the ruling affirmed the central conclusion of a Nueces County jury, which found Centocor...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles